1. Structure-based virtual screening of natural compounds against wild and mutant (R1155K, A1156T and D1168A) NS3-4A protease of Hepatitis C virus.
- Author
-
Samantaray M, Pattabiraman R, Murthy TPK, Ramaswamy A, Murahari M, Krishna S, and Kumar SB
- Subjects
- Humans, Binding Sites, Biological Products chemistry, Biological Products pharmacology, Drug Design, Hydrogen Bonding, Ligands, Molecular Docking Simulation, Molecular Dynamics Simulation, Principal Component Analysis, Protease Inhibitors chemistry, Protease Inhibitors pharmacology, Protein Binding, Serine Proteases, Structure-Activity Relationship, Antiviral Agents pharmacology, Antiviral Agents chemistry, Hepacivirus drug effects, Hepacivirus enzymology, Hepacivirus genetics, Mutation, Viral Nonstructural Proteins antagonists & inhibitors, Viral Nonstructural Proteins chemistry, Viral Nonstructural Proteins metabolism, Viral Nonstructural Proteins genetics
- Abstract
NS3-4A, a serine protease, is a primary target for drug development against Hepatitis C Virus (HCV). However, the effectiveness of potent next-generation protease inhibitors is limited by the emergence of mutations and resulting drug resistance. To address this, in this study a structure-based drug design approach is employed to screen a large library of 7320 natural compounds against both wild-type and mutant variants of NS3-4A protease. Telaprevir, a widely used protease inhibitor, was recruited as the control drug. The top 10 compounds with favorable binding affinities underwent drug-likeness evaluation. Based on ADMET studies, complexes of NP_024762 and NP_006776 were selected for molecular dynamic simulations. Principal component analysis (PCA) was employed to explore the conformational space and protein dynamics of the protein-ligand complex using a Free Energy Landscape (FEL) approach. The cosine values obtained from FEL analysis ranged from 0 to 1, and eigenvectors with cosine values below 0.2 were chosen for further analysis. To forecast binding free energies and evaluate energy contributions per residue, the MM-PBSA method was employed. The results highlighted the crucial role of amino acids in the catalytic domain for the binding of the protease with phytochemicals. Stable associations between the top compounds and the target protease were confirmed by the formation of hydrogen bonds in the binding pocket involving residues: His1057, Gly1137, Ser1139, and Ala1157. These findings suggest the potential of these compounds for further validation through biological evaluation.Communicated by Ramaswamy H. Sarma.
- Published
- 2024
- Full Text
- View/download PDF